Dupilumab: a milestone in the treatment of atopic dermatitis

Lancet. 2016 Jan 2;387(10013):4-5. doi: 10.1016/S0140-6736(15)00389-X. Epub 2015 Oct 8.

Authors

Athanasios Tsianakas¹, Sonja Ständer²

Affiliations

¹ Department of Dermatology, University Hospital Muenster, 48149 Muenster, Germany.
² Department of Dermatology, University Hospital Muenster, 48149 Muenster, Germany. Electronic address: sonja.staender@uni-muenster.de.

PMID: 26454359
DOI: 10.1016/S0140-6736(15)00389-X

No abstract available

Publication types

Comment

MeSH terms

Antibodies, Monoclonal / therapeutic use*
Dermatitis, Atopic / drug therapy*
Female
Humans
Interleukin-4 Receptor alpha Subunit / antagonists & inhibitors*
Male

Substances

Antibodies, Monoclonal
Interleukin-4 Receptor alpha Subunit